InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

Current share price for RHY : $0.075 0.003 (4.17%)+

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 Breast Cancer Diagnostic Test Update 21 Sep 2023 9:27AM $0.300 $0.075 fallen by 75%
$27 Notification of cessation of securities - RHY 18 Sep 2023 4:47PM $0.335 $0.075 fallen by 77.61%
$27 RHY Contracts with Nutripath on Automation 13 Sep 2023 9:59AM $0.330 $0.075 fallen by 77.27%
$27 Application for quotation of securities - RHY 12 Sep 2023 9:20AM $0.345 $0.075 fallen by 78.26%
$27 Cleansing Notice 12 Sep 2023 9:14AM $0.345 $0.075 fallen by 78.26%
$27 RHY 2023 AGM Nominations & Proxy Form 1 Sep 2023 3:19PM $0.390 $0.075 fallen by 80.77%
$27 Appendix 4G and Corporate Governance Statement 31 Aug 2023 4:40PM $0.380 $0.075 fallen by 80.26%
$27 RHY FY2023 Annual Report 31 Aug 2023 4:35PM $0.380 $0.075 fallen by 80.26%
$27 Appendix 4E 31 Aug 2023 4:23PM $0.380 $0.075 fallen by 80.26%
$27 Application for quotation of securities - RHY 8 Aug 2023 2:11PM $0.425 $0.075 fallen by 82.35%
$27 Change of Directors Interest Notice 8 Aug 2023 2:04PM $0.425 $0.075 fallen by 82.35%
$27 Cleansing Notice 8 Aug 2023 2:04PM $0.425 $0.075 fallen by 82.35%
$27 Appendix 3Y - Change of Directors Interest Notice 1 Aug 2023 3:42PM $0.440 $0.075 fallen by 82.95%
$27 Appendix 4C and Market Update 31 Jul 2023 10:21AM $0.460 $0.075 fallen by 83.70%
$27 Bioshares Summit Presentation 25 Jul 2023 12:12PM $0.470 $0.075 fallen by 84.04%
$27 Appointment of Independent Deputy Chair 4 Jul 2023 10:04AM $0.490 $0.075 fallen by 84.69%
$27 Rhythm Establishes UK Subsidiary for Market Entry 3 Jul 2023 10:09AM $0.410 $0.075 fallen by 81.71%
$27 Notification of cessation of securities - RHY 30 Jun 2023 2:17PM $0.415 $0.075 fallen by 81.93%
$27 Revised Securities Trading Policy 23 Jun 2023 10:28AM $0.420 $0.075 fallen by 82.14%
$27 Investor Presentation 20 Jun 2023 9:21AM $0.460 $0.075 fallen by 83.70%
$27 Rhythm Continues Platform Expansion Program for Other Cancer 19 Jun 2023 10:03AM $0.485 $0.075 fallen by 84.54%
$27 ColoSTAT Poster Presentation at ASCO Annual Meeting 6 Jun 2023 9:46AM $0.490 $0.075 fallen by 84.69%
$27 Notification of cessation of securities - RHY 26 May 2023 1:06PM $0.380 $0.075 fallen by 80.26%
$27 Response to ASX Query 25 May 2023 10:38AM $0.415 $0.075 fallen by 81.93%
$27 UK Strategic Partnership with LINK Medical Solutions 24 May 2023 10:02AM $0.450 $0.075 fallen by 83.33%

276 - 300 of 652 results

Page 12 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.